Vir Biotechnology Inc’s filing revealed that its Former Director GEORGE SCANGOS acquired Company’s shares for reported $0.27 million on Jun 10 ’25. In the deal valued at $5.48 per share,50,000 shares were bought.
Then, GEORGE SCANGOS bought 50,000 shares, generating $270,590 in total proceeds.
Before that, Napolitano Janet sold 3,200 shares. Vir Biotechnology Inc shares valued at $16,149 were divested by the Director at a price of $5.05 per share. As a result of the transaction, Napolitano Janet now holds 16,416 shares, worth roughly $88974.72.
JP Morgan downgraded its Vir Biotechnology Inc [VIR] rating to a Neutral from a an Overweight in a research note published on January 29, 2024; the price target was decreased to $9 from $23. A number of analysts have revised their coverage, including BofA Securities’s analysts, who decreased its forecast for the stock in early September from “a Buy” to “a Neutral”. JP Morgan also remained covering VIR and has increased its forecast on March 06, 2023 with a “an Overweight” recommendation from previously “Neutral” rating. Goldman revised its rating on February 21, 2023. It rated VIR as “a Buy” which previously was an “a Neutral”.
Price Performance Review of VIR
On Tuesday, Vir Biotechnology Inc [NASDAQ:VIR] saw its stock fall -0.18% to $5.42. Over the last five days, the stock has gained 3.63%. Vir Biotechnology Inc shares have fallen nearly -26.16% since the year began. Nevertheless, the stocks have fallen -54.76% over the past one year.
How much short interest is there in Vir Biotechnology Inc?
A steep rise in short interest was recorded in Vir Biotechnology Inc stocks on 2025-05-15, growing by 0.78 million shares to a total of 10.94 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-15 was 10.17 million shares. There was a rise of 7.09%, which implies that there is a positive sentiment for the stock.
